Apellis Pharmaceuticals, Inc. (APLS)
40.41
+0.02
(+0.05%)
USD |
NASDAQ |
Apr 02, 16:00
40.43
+0.02
(+0.05%)
Pre-Market: 08:10
Apellis Pharmaceuticals Price : 40.41 for April 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 177.34 |
| Eli Lilly & Co. | 935.58 |
| Agios Pharmaceuticals, Inc. | 35.20 |
| Scholar Rock Holding Corp. | 50.01 |
| BridgeBio Pharma, Inc. | 73.15 |
Price Related Metrics
| PE Ratio | 327.21 |
| PS Ratio | 5.115 |
| Price to Book Value | 13.96 |
| Price to Free Cash Flow | 114.06 |
| Earnings Yield | 0.31% |
| Market Cap | 5.168B |
| Operating PE Ratio | 92.63 |
| Normalized PE Ratio | 327.21 |